SOAT1 and systemic lupus erythematosus: As multiple cytokines share gp130 subunit as the signal transducer, inhibition of JAK/STAT pathway allows simultaneous disruption of multiple cytokines’ signaling (75) and JAK inhibitors thus represent potential therapeutic agents to derail gp130 downstream signaling cascades in SLE.